Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1α and estrogen receptors

Molecular Endocrinology

Volumn 13, Issue 12, 1999, Pages 2137-2150

  Thénot, Sandrine ^a   Bonnet, Sandrine ^a   Boulahtouf, Abdelhay ^a   Margeat, Emmanuel ^b   Royer, Catherine A ^b   Borgna, Jean Louis ^c   Cavailles, Vincent ^a  

^a UNIV MONTPELLIER   (France)

^b CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; LIGAND; STEROID HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION INTERMEDIARY FACTOR 1 ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE ACTIVITY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY;

EID: 0033330261     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.12.0387     Document Type: Article

References (73)

1. Structure and function of the estrogen receptor
2. Steroid hormone receptors: Many actors in search of a plot
3. Cloning of a novel receptor expressed in rat prostate and ovary
4. Estrogen receptor β: Re-evaluation of estrogen and antiestrogen signaling
5. Transcription factors 3: Nuclear receptors
6. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding
7. Molecular basis of agonism and antagonism in the oestrogen receptor
8. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
9. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
10. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid
11. A structural role for hormone in the thyroid hormone receptor
12. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
13. Role of coactivators and co-repressors in the mechanism of steroid/thyroid receptor action
14. Coactivators and corepressors as mediators of nuclear receptor function: An update
15. Coactivator and corepressor complexes in nuclear receptor function
16. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
17. The histone acetylase PCAF is a nuclear receptor coactivator
18. The transcriptional coactivators p300 and CBP are histone acetyltransferases
19. Steroid receptor coactivator-1 is a histone acetyltransferase
20. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
21. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex
22. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
23. A novel human SRB/ MED-containing cofactor complex, SMCC, involved in transcription regulation
24. Estrogen receptor mutants which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo
25. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA
26. Estrogen receptor ligands modulate its interaction with DNA
27. Allosteric effects of DNA on transcriptional regulators
28. Estrogen response elements function as allosteric modulators of estrogen receptor conformation
29. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA
30. Mechanisms of transcriptional activation by retinoic acid receptors
31. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
32. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine
33. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex
34. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA
35. A new version of the two-hybrid assay for detection of protein-protein interactions
36. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTlF1
37. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TlF1
38. Interaction of proteins with transcriptionally active estrogen receptors
39. A signature motif in transcriptional coactivators mediates binding to nuclear receptors
40. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
41. The novel estrogen receptor-β subtype: Potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens
42. Fluorescence anisotropy as says implicate protein-protein interactions in regulating trp repressor DNA binding
43. Nuclear protein CBP is a coactivator for the transcription factor CREB
44. Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy
45. A possible involvement of TlF1α and TlF1β in the epigenetic control of transcription by nuclear receptors
46. The putative cofactor TlF1α is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors
47. Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1
48. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
49. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
50. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells
51. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
52. Isoforms of steroid receptor coactivator 1 differ in their ability to potentiate transcription by the oestrogen receptor
53. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-γ
54. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TlF2
55. Multiple receptor interaction domains of GRIP1 function in synergy
56. An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors
57. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
58. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
59. The coactivator TlF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
60. Structure and specificity of nuclear receptor-coactivator interactions
61. Molecular determinants of the estrogen receptor-coactivator interface
62. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog
63. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ
64. Effects of estradiol-17β analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression
65. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
66. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain
67. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
68. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
69. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity
70. Estrogen receptors α and β form heterodimers on DNA
71. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
72. Characterization of the proximal estrogen-responsive element of human cathepsin D gene
73. Numerical analysis of binding data: Advantages, practical aspects, and implications